326 related articles for article (PubMed ID: 31407609)
1. apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population Study.
Zheng KH; Arsenault BJ; Kaiser Y; Khaw KT; Wareham NJ; Stroes ESG; Boekholdt SM
J Am Heart Assoc; 2019 Aug; 8(16):e013020. PubMed ID: 31407609
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease.
Ljungberg J; Holmgren A; Bergdahl IA; Hultdin J; Norberg M; Näslund U; Johansson B; Söderberg S
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246959
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort.
Arsenault BJ; Boekholdt SM; Dubé MP; Rhéaume E; Wareham NJ; Khaw KT; Sandhu MS; Tardif JC
Circ Cardiovasc Genet; 2014 Jun; 7(3):304-10. PubMed ID: 24704946
[TBL] [Abstract][Full Text] [Related]
4. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
[TBL] [Abstract][Full Text] [Related]
5. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
6. ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.
Tastet L; Capoulade R; Shen M; Clavel MA; Côté N; Mathieu P; Arsenault M; Bédard É; Tremblay A; Samson M; Bossé Y; Dumesnil JG; Arsenault BJ; Beaudoin J; Bernier M; Després JP; Pibarot P
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440006
[TBL] [Abstract][Full Text] [Related]
7. Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).
Albers JJ; Slee A; O'Brien KD; Robinson JG; Kashyap ML; Kwiterovich PO; Xu P; Marcovina SM
J Am Coll Cardiol; 2013 Oct; 62(17):1575-9. PubMed ID: 23973688
[TBL] [Abstract][Full Text] [Related]
8. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2014 Feb; 63(5):470-7. PubMed ID: 24161338
[TBL] [Abstract][Full Text] [Related]
9. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
10. Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity.
Ying X; Qian Y; Jiang Y; Jiang Z; Song Z; Zhao C
Acta Diabetol; 2012 Dec; 49(6):465-72. PubMed ID: 22965469
[TBL] [Abstract][Full Text] [Related]
11. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
van der Steeg WA; Holme I; Boekholdt SM; Larsen ML; Lindahl C; Stroes ES; Tikkanen MJ; Wareham NJ; Faergeman O; Olsson AG; Pedersen TR; Khaw KT; Kastelein JJ
J Am Coll Cardiol; 2008 Feb; 51(6):634-42. PubMed ID: 18261682
[TBL] [Abstract][Full Text] [Related]
13. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
[TBL] [Abstract][Full Text] [Related]
14. Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol.
Marrero N; Jha K; Razavi AC; Boakye E; Anchouche K; Dzaye O; Budoff MJ; Tsai MY; Shah SJ; Rotter JI; Guo X; Yao J; Blumenthal RS; Thanassoulis G; Post WS; Blaha MJ; Whelton SP
Circ Cardiovasc Imaging; 2024 Jun; 17(6):e016372. PubMed ID: 38889215
[TBL] [Abstract][Full Text] [Related]
15. Elevated Apolipoprotein B/A-1 Ratio is Associated With an Increased Risk of Aortic Stenosis: Experience From the AMORIS Cohort.
Ivert T; Hammar N; Talbäck M; Malmström H; Leander K; Walldius G
Heart Lung Circ; 2021 Jul; 30(7):1050-1057. PubMed ID: 33461915
[TBL] [Abstract][Full Text] [Related]
16. Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.
van Capelleveen JC; Lee SR; Verbeek R; Kastelein JJP; Wareham NJ; Stroes ESG; Hovingh GK; Khaw KT; Boekholdt SM; Witztum JL; Tsimikas S
J Clin Lipidol; 2018; 12(6):1493-1501.e11. PubMed ID: 30249512
[TBL] [Abstract][Full Text] [Related]
17. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Lipoprotein(a)-Levels in Patients ≥70 Years of Age With Versus Without Aortic Valve Stenosis.
Mahabadi AA; Kahlert P; Kahlert HA; Dykun I; Balcer B; Forsting M; Heusch G; Rassaf T
Am J Cardiol; 2018 Aug; 122(4):645-649. PubMed ID: 29954600
[TBL] [Abstract][Full Text] [Related]
20. Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.
Capoulade R; Yeang C; Chan KL; Pibarot P; Tsimikas S
JAMA Cardiol; 2018 Dec; 3(12):1212-1217. PubMed ID: 30476957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
